Monday, December 02, 2013 1:31:05 PM
After hearing of your story and background, I don't feel quite as duped by good Ole Cortex and her touters as I did a mere minute ago.
It's a horrible shame to hear that a weathered bio-tech broker's misfortune and near financial ruin was primarily the result of a Cortex investment and the words of her leaders. His understanding of Bio-techs and their market, including their battles and means to exponential value as well as their instability, were obviously far more understood by him as it was a part of his daily rhetoric. His due diligence must have far superseded that of my willingness to believe the likes and notions of our board experts. It's a tragic story.
What's even more tragic however, is to hear that a family, with a higher understanding of Neurology backed by education and practice, had their hopes dwindled, dashed, mislead, and lost as a result of an FDA disapproval or of our company's leaders gross incompetence. Clearly you had a greater knowledge of your venture than most of us, and in so carried a much larger investment of hope which resulted in a far grander loss than all of us. The hopes of a Cortex molecule aiding in your father's recovery can never be recovered whereas my dollars can. Sad. It's a monumental shame what Cortex has cost so many of us in the I-hub community alone both financially and otherwise.
I can only hope that something does come of this investment before your story hits even closer to my home. I'm out nearly a half a million dollars, but the thought of a Cortex molecule saving someone close to me, yields far greater than this investment's monetary value ever could.
GLTY!
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM